Assessing the implications of the Dutch cross-border injunctions for pharmaceutical companies across Europe

C.J.J.C. van Nispen

Research output: Book / ReportReportAcademic

Original languageEnglish
PublisherUnknown Publisher
Commissioning bodyCongresbundel Patent Law Conference (IIR)
Publication statusPublished - 1995

Cite this